Loading…
VEGF b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
Saved in:
Published in: | British journal of cancer 2008-04, Vol.98 (8), p.1366-1379 |
---|---|
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 0007-0920 1532-1827 |
DOI: | 10.1038/sj.bjc.6604308 |